Opportunity Information: Apply for RFA CA 17 041
The NIH funding opportunity "Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01)" (RFA-CA-17-041) is a cooperative agreement grant tied to the Beau Biden Cancer Moonshot Initiative, a national effort designed to speed up progress in cancer research and, in this case, cancer prevention and early detection. The central goal of the announcement is to find better, more practical ways to identify people and families who have an inherited genetic risk for cancer (often called inherited cancer syndromes) and to improve how health systems actually deliver proven, evidence-based care to those individuals once they are identified. Inherited risk can be under-recognized in routine care, so the FOA emphasizes both "case ascertainment" (locating and correctly identifying at-risk individuals) and "delivery" (making sure recommended testing, counseling, screening, and follow-up care happen reliably in the real world).
This FOA is explicitly aligned with a scientific priority highlighted by the Cancer Moonshot Blue Ribbon Panel, particularly Recommendation E, which focuses on realizing the potential of cancer prevention and early detection. The Blue Ribbon Panel language calls for initiatives that strengthen early detection, genetic testing, genetic counseling, and the broader knowledge base around mechanisms and biomarkers involved in cancer development. Importantly, it also stresses demonstration projects, meaning the projects should not stay theoretical. They should show, in practical and measurable ways, how improved approaches to genetic risk identification and screening can save lives, improve quality of life, and potentially reduce overall healthcare costs by catching cancers earlier or preventing them altogether.
The award mechanism is a U01 cooperative agreement, which signals that NIH expects substantial programmatic involvement from the federal scientific staff during the project. In practical terms, that usually means awardees are not only funded to run their projects but also coordinate closely with NIH on milestones, study design considerations, data-sharing expectations, and cross-site collaboration when applicable. The activity category is listed under education and health, and the CFDA numbers associated with this opportunity are 93.393 and 93.399, both tied to NCI-related research and cancer control efforts.
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and tribal organizations that are not federally recognized. The FOA also allows public housing authorities and Indian housing authorities, nonprofits (both 501(c)(3) and non-501(c)(3), as long as they are not institutions of higher education in that category), for-profit organizations (other than small businesses), small businesses, and other entities as specified. It also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This breadth reflects an emphasis on reaching diverse communities and enabling projects that can operate in many different healthcare and public health settings.
At the same time, there are clear limits on foreign participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, the FOA does allow "foreign components" as defined in NIH policy, meaning a U.S. applicant may, when justified and compliant with NIH rules, include certain foreign elements in the work (for example, collaborations, data, or specialized activities), even though the main applicant organization must be domestic.
Administratively, the sponsoring agency is the National Institutes of Health, and the original closing date listed for applications was January 9, 2018, with a creation date of September 1, 2017. The public summary does not specify an award ceiling or the expected number of awards, indicating those details were either not provided in the excerpted source data or were left unspecified in the summarized listing.
In plain terms, this opportunity was designed to move the field beyond simply knowing that inherited cancer risk exists and toward building workable, scalable approaches that help health systems and communities find at-risk people earlier, connect them with genetic testing and counseling, and ensure they receive the right preventive care and screening over time. The Moonshot framing and the Blue Ribbon Panel emphasis suggest that applicants were expected to focus on high-impact, real-world implementation strategies and demonstration projects that can show measurable benefits in outcomes, patient experience, and potentially cost.Apply for RFA CA 17 041
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.399.
- This funding opportunity was created on 2017-09-01.
- Applicants must submit their applications by 2018-01-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) (RFA-CA-17-041)
What is this NIH funding opportunity?
This opportunity is the NIH Funding Opportunity Announcement (FOA) titled "Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01)" with FOA number RFA-CA-17-041. It supports projects focused on inherited cancer syndromes, using the U01 cooperative agreement mechanism.
What is the main goal of RFA-CA-17-041?
The central goal is to develop and demonstrate better, practical ways to (1) identify individuals and families with inherited genetic risk for cancer (inherited cancer syndromes) and (2) improve how health systems deliver proven, evidence-based care after those individuals are identified.
What does the FOA mean by "case ascertainment"?
"Case ascertainment" refers to locating and correctly identifying people who are at risk for inherited cancer syndromes, especially in real-world settings where inherited risk can be under-recognized during routine care.
What does the FOA mean by improving "delivery" of care?
How is this opportunity connected to the Cancer Moonshot?
The FOA is tied to the Beau Biden Cancer Moonshot Initiative, a national effort intended to accelerate progress in cancer research. In this FOA, the Moonshot connection is specifically focused on cancer prevention and early detection through improved identification of inherited risk and improved care delivery for those at risk.
Which Moonshot scientific priority does this FOA align with?
This FOA is explicitly aligned with a scientific priority highlighted by the Cancer Moonshot Blue Ribbon Panel, particularly Recommendation E, which focuses on realizing the potential of cancer prevention and early detection.
What does the Blue Ribbon Panel emphasis imply for proposed projects?
The Blue Ribbon Panel language emphasizes strengthening early detection, genetic testing, genetic counseling, and the knowledge base around mechanisms and biomarkers involved in cancer development. It also stresses demonstration projects, meaning projects should show practical, measurable approaches rather than staying purely theoretical.
What kind of outcomes are projects expected to demonstrate?
Based on the Moonshot framing and the Blue Ribbon Panel emphasis, projects are expected to demonstrate measurable benefits such as saving lives, improving quality of life, and potentially reducing healthcare costs by preventing cancers or catching them earlier through better identification and screening approaches.
What type of grant mechanism is a U01?
The award mechanism is a U01 cooperative agreement. This signals substantial programmatic involvement from NIH federal scientific staff during the project, beyond what is typical for many other grant mechanisms.
What does "substantial involvement" from NIH staff mean in practice?
In practical terms, a U01 cooperative agreement typically means awardees coordinate closely with NIH on elements such as milestones, study design considerations, data-sharing expectations, and cross-site collaboration when applicable.
What is the sponsoring agency for this FOA?
The sponsoring agency is the National Institutes of Health (NIH), and the CFDA numbers listed (93.393 and 93.399) are associated with NCI-related research and cancer control efforts.
What activity category is associated with this opportunity?
The activity category is listed under education and health.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governmental entities, including state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and tribal organizations that are not federally recognized.
Are nonprofits eligible to apply?
Yes. Nonprofits are eligible, including both 501(c)(3) and non-501(c)(3) organizations, as long as they fit within the categories described in the FOA summary (including the note that certain nonprofit categories are specified as "not institutions of higher education" in that category).
Are for-profit organizations eligible to apply?
Yes. The FOA allows for-profit organizations (other than small businesses) and also includes small businesses among eligible applicants.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly highlights faith-based or community-based organizations as eligible applicants.
Are U.S. territories eligible to apply?
Yes. The FOA includes U.S. territories or possessions among the additional eligible applicants.
Are federally recognized tribes eligible to apply?
Yes. Federally recognized Native American tribal governments are eligible applicants under this FOA.
Are tribal organizations that are not federally recognized eligible to apply?
Yes. The FOA includes tribal organizations that are not federally recognized among eligible applicants.
Does the FOA name specific institution types as eligible?
Yes. It highlights multiple institution types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Are public housing authorities eligible?
Yes. The FOA allows public housing authorities and Indian housing authorities as eligible applicants.
Are foreign (non-U.S.) organizations eligible to apply as the main applicant?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply.
Can a U.S. applicant include any foreign involvement in the project?
Yes. The FOA allows "foreign components" as defined in NIH policy. This means a U.S. applicant may include certain foreign elements (such as collaborations, data, or specialized activities) when justified and consistent with NIH rules, even though the main applicant organization must be domestic.
When was this FOA created, and what was the listed application closing date?
The creation date listed is September 1, 2017, and the original closing date listed for applications was January 9, 2018.
Does the provided summary specify the maximum award amount (award ceiling)?
No. The public summary provided does not specify an award ceiling.
Does the provided summary specify how many awards NIH expected to make?
No. The public summary does not state the expected number of awards.
What types of approaches does this FOA encourage overall?
In plain terms, the opportunity was designed to move beyond simply recognizing inherited cancer risk and toward building workable, scalable approaches that help health systems and communities identify at-risk people earlier, connect them with genetic testing and counseling, and ensure appropriate preventive care and screening happens over time.
Why does the FOA emphasize real-world implementation and demonstration projects?
The Cancer Moonshot and Blue Ribbon Panel framing emphasizes practical demonstration projects to show that improved approaches can work in real settings, produce measurable benefits in outcomes and patient experience, and potentially reduce costs by preventing cancers or detecting them earlier.
Browse more opportunities from the same category: Education, Health
Next opportunity: Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
Previous opportunity: Biology of Lung, and Head and Neck Preneoplasias (R21)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 17 041
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 17 041) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33) Apply for RFA DA 18 016 Funding Number: RFA DA 18 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $650,000 |
| NINR Center of Excellence (P30) Apply for RFA NR 17 004 Funding Number: RFA NR 17 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18) Apply for PAR 17 486 Funding Number: PAR 17 486 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| New Onset Depressive Symptoms in Acute Illness (R01 Clinical Trial Not Allowed) Apply for PA 17 488 Funding Number: PA 17 488 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| New Onset Depressive Symptoms in Acute Illness (R21 Clinical Trial Not Allowed) Apply for PA 17 487 Funding Number: PA 17 487 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Addressing Chronic Wound Trajectories Through Social Genomics Research (R01 Clinical Trial Optional) Apply for PA 17 492 Funding Number: PA 17 492 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R01 Clinical Trial Optional) Apply for PAR 17 491 Funding Number: PAR 17 491 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01) Apply for RFA CA 17 052 Funding Number: RFA CA 17 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $425,000 |
| Pediatric Immunotherapy Translational Science Network (PI-TSN)(U54) Apply for RFA CA 17 050 Funding Number: RFA CA 17 050 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,600,000 |
| Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01) Apply for RFA CA 17 051 Funding Number: RFA CA 17 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R21 Clinical Trial Optional) Apply for PAR 17 490 Funding Number: PAR 17 490 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Addressing Chronic Wound Trajectories Through Social Genomics Research (R21 Clinical Trial Optional) Apply for PA 17 493 Funding Number: PA 17 493 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NCI Outstanding Investigator Award (R35) Apply for PAR 17 494 Funding Number: PAR 17 494 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 303 Funding Number: PAR 18 303 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) Apply for PAR 18 313 Funding Number: PAR 18 313 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed Apply for PAR 18 310 Funding Number: PAR 18 310 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) Apply for PAR 18 307 Funding Number: PAR 18 307 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) Apply for PAR 18 317 Funding Number: PAR 18 317 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) Apply for RFA CA 17 033 Funding Number: RFA CA 17 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) Apply for RFA CA 17 038 Funding Number: RFA CA 17 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 17 041", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
